Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)

Starting soon · Not applicable

Conditions studied: HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV), Opioid Use Disorder

In brief

Evaluate the feasibility, acceptability, and usability of the intervention (primary outcomes) and coping skills and resilience (secondary outcomes) of the telehealth intervention over two months (8 weekly sessions) in a waitlist-controlled, randomized pilot trial using a cross-over design among 40 PWID. The primary outcomes will be feasibility, acceptability, and usability of the intervention. Secondary outcomes will be increased coping skills and resilience, which in turn, will increase status neutral HIV and HCV care and MOUD uptake (longer-term outcomes). Outcomes will be assessed using pre- and post-intervention surveys.

Key facts

Study ID

NCT06799702

Run by

University of Georgia

People needed

50

Starts

2026-08-01

Expected to finish

2028-07-31

Last updated by the study team

2025-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• People who actively inject drugs verified by visible injection stigmata (needle tracks)
• HIV negative
• Adult (≥18 years)
• lives in rural areas

You may not qualify if…

• Living with HIV
• Lives in urban areas
• Not proficient in English

Where it is running

• MedLink Georgia — Colbert, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.